Press Releases
Jan 19, 2023
January 12, 2023
Alume Co-Founder Roger Tsien Inducted Into National Inventors Hall of Fame
Jan 10, 2023
Alume Biosciences Secures $13M In Series B Financing
Jan 10, 2023
Jan 9, 2023
Jan 9, 2023
Dec 12, 2022
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
November 21, 2022
Graybug and CalciMedica Enter into Definitive Merger Agreement
Nov 08, 2022
ProciseDx Announces FDA Clearance of ProciseDx instrument and C Reactive Protein (CRP) Assay
November 1, 2022
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
August 23, 2022
May 26, 2022
April 26, 2022
Castle Biosciences Completes Acquisition of AltheaDx
April 20, 2022
February 22, 2021
February 18, 2021
TransCode Therapeutics Announces Key Appointments
February 17, 2021
Micronoma Raises $3.5 Million in Convertible Note Financing
December 15, 2020
BioAtla Announces Pricing of Initial Public Offering
December 15, 2020
Castle Biosciences Announces Pricing of $232 Million Public Offering of Public Stock
December 9, 2020
Micronoma Establishes Scientific Advisory Board
November 5, 2020
October 15, 2020
Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
October 13, 2020
Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer
October 5, 2020
September 30, 2020
Micronoma Appoints Magda Marquet Chairman of the Board
September 29, 2020
ProciseDx Completes Distribution Agreements with D.I.D. in Italy and BHR in the United Kingdom
September 28, 2020
September 18, 2020
September 9, 2020
ProciseDx Achieves CE Mark for Infliximab and Adalimumab Point of Care Testing
August 13, 2020
Micronoma Launches with $3 Million Seed Funding
August 10, 2020
July 29, 2020
Arcturus Therapeutics Announces Pricing of $173 Million Public Offering of Common Stock
July 21, 2020
July 21, 2020
July 15, 2020
BioAtla Raises $72.5 Million in Series D Financing
July 8, 2020
May 26, 2020
May 22, 2020
CalciMedica Raises $15 Million in Series C Financing Round Led by Valence Life Sciences
May 21, 2020
May 18, 2020
Seraphina Therapeutics – The First Potential Essential Fatty Acid Discovered in 90 Years
May 8, 2020
May 4, 2020
US FDA Allows Trial to Proceed for Alume Biosciences’ Nerve Imaging Candidate
May 1, 2020
Alume Biosciences Completes $5.5M Series A Financing
April 27, 2020
Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
April 27, 2020
Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test
April 13, 2020
March 27, 2020
Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System
March 11, 2020
March 4, 2020
Articles
February 22, 2021
October 11, 2020
San Diego biotechs have plunged into the fight against COVID-19. Here’s what they’re doing
July 9, 2020
Pandemic Perspectives – Interview with Magda Marquet
May 18, 2020
Arcturus Therapeutics and Duke-NUS – LUNAR-COV19
April 17, 2020
October 10, 2018
Scripps Research Creates Board of Overseers
February 13, 2017
La Jolla Institute Board of Directors Elects Biotech Entrepreneur
January 20, 2016
The San Diego Technology Archive – UCSD Libraries
December 17, 2015
September 10, 2015
Executive Q&A: Magda Marquet of Althea Technologies and Alma Life Sciences
February 27, 2013